Goldman Sachs Group »

Liminatus Pharma Inc A shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Liminatus Pharma Inc A (LIMN) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Liminatus Pharma Inc A

Tip: Access up to 7 years of quarterly data

All positions including Liminatus Pharma Inc A held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Liminatus Pharma Inc A by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.4k 40k 0.11

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
State Str Spdr S&p 500 Etf T CMN (SPY)
Apple CMN (AAPL)
Micron Technology CMN (MU)
Microsoft Corp CMN (MSFT)
Taiwan Semiconductor Manufac CMN (TSM)
Alphabet CMN (GOOGL)
Sandisk Corp CMN (SNDK)
Amazon CMN (AMZN)
Invesco Qqq Tr CMN (QQQ)
Broadcom CMN (AVGO)
Vaneck Etf Trust CMN (SMH)
Tesla CMN (TSLA)
Meta Platforms CMN (META)
Alphabet CMN (GOOG)

View all positions for Goldman Sachs Group

Top funds holding Liminatus Pharma Inc A

Cygnus Capital Advisors
XTX Topco
Geode Capital Management
Citadel Advisors
Vanguard Capital Management
Goldman Sachs Group
Intl Fcstone
Vanguard Fiduciary Trust
State Street Corporation
UBS Group
JustInvest
Tower Research Capital
Citigroup
Barclays
BlackRock

View all funds holding Liminatus Pharma Inc A